SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-19-006048
Filing Date
2019-05-07
Accepted
2019-05-07 16:03:45
Documents
8
Period of Report
2019-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K q119_epr-8k.htm 8-K 32908
2 EXHIBIT 99.1 ex991q12019eprfinal.htm EX-99.1 31024
3 ex991q12019eprfinal001.jpg GRAPHIC 194442
4 ex991q12019eprfinal002.jpg GRAPHIC 225182
5 ex991q12019eprfinal003.jpg GRAPHIC 200877
6 ex991q12019eprfinal004.jpg GRAPHIC 252665
7 ex991q12019eprfinal005.jpg GRAPHIC 86418
8 ex991q12019eprfinal006.jpg GRAPHIC 26993
  Complete submission text file 0001628280-19-006048.txt   1424333
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37833 | Film No.: 19803031
SIC: 2836 Biological Products, (No Diagnostic Substances)